Advertisement
U.S. markets open in 3 hours 19 minutes

Nevro Corp. (NVRO)

NYSE - NYSE Delayed Price. Currency in USD
14.09+0.36 (+2.62%)
At close: 04:00PM EDT
14.21 +0.12 (+0.85%)
After hours: 05:48PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close13.73
Open13.79
Bid5.64 x 900
Ask22.54 x 1000
Day's Range13.56 - 14.24
52 Week Range13.36 - 39.67
Volume458,427
Avg. Volume495,178
Market Cap512.846M
Beta (5Y Monthly)0.90
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NVRO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nevro Corp.
    Analyst Report: Boston Scientific CorporationBoston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
    Rating
    Fair Value
    Economic Moat
    17 hours agoMorningstar
View more